BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND BCL9, LGS, 607, ENSG00000116128, MGC131591
87 results:

  • 1. Long non-coding RNA as a potential diagnostic and prognostic biomarker in melanoma: A systematic review and meta-analysis.
    Masrour M; Khanmohammadi S; Fallahtafti P; Hashemi SM; Rezaei N
    J Cell Mol Med; 2024 Feb; 28(3):e18109. PubMed ID: 38193829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Comparing P53 expression and genome-wide transcriptome profiling to Comet assay in lymphocytes from melanoma patients and healthy controls.
    Najafzadeh M; Naeem P; Ghaderi N; Jafarinejad S; Karimi Z; Ghaderi M; Akhbari P; Ghaderi R; Farsi P; Wright A; Anderson D
    Sci Rep; 2023 Nov; 13(1):18858. PubMed ID: 37914759
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Preoperative vascular heterogeneity based on dynamic susceptibility contrast MRI in predicting spatial pattern of locally recurrent high-grade gliomas.
    Wang H; Zeng L; Wu H; Tian J; Xie H; Zhang L; Ran Q; Zhong P; Chen L; Yi L; Wang S
    Eur Radiol; 2024 Mar; 34(3):1982-1993. PubMed ID: 37658897
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Nano-vaccines combining customized in situ anti-PD-L1 depot for enhanced tumor immunotherapy.
    Chen Q; Sun M; Li Y; Huang L; Zu C; Kuang X; Zhao J; Hao M; Ma T; Li C; Tu J; Sun C; Du Y
    Nanomedicine; 2023 Sep; 53():102693. PubMed ID: 37343780
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. CT radiomics compared to a clinical model for predicting checkpoint inhibitor treatment outcomes in patients with advanced melanoma.
    Ter Maat LS; van Duin IAJ; Elias SG; Leiner T; Verhoeff JJC; Arntz ERAN; Troenokarso MF; Blokx WAM; Isgum I; de Wit GA; van den Berkmortel FWPJ; Boers-Sonderen MJ; Boomsma MF; van den Eertwegh FJM; de Groot JWB; Piersma D; Vreugdenhil A; Westgeest HM; Kapiteijn E; van Diest PJ; Pluim JPW; de Jong PA; Suijkerbuijk KPM; Veta M
    Eur J Cancer; 2023 May; 185():167-177. PubMed ID: 36996627
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. All-Nontoxic Fluorescent Probe for Biothiols and Its Clinical Applications for Real-Time Glioblastoma Visualization.
    Kim Y; Kim J; An JM; Park CK; Kim D
    ACS Sens; 2023 Apr; 8(4):1723-1732. PubMed ID: 36967520
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Transfer RNA-derived small RNAs (tsRNAs) sequencing revealed a differential expression landscape of tsRNAs between glioblastoma and low-grade glioma.
    Tu M; Zuo Z; Chen C; Zhang X; Wang S; Chen C; Sun Y
    Gene; 2023 Mar; 855():147114. PubMed ID: 36526122
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma.
    Qiao J; Liu J; Jacobson JC; Clark RA; Lee S; Liu L; An Z; Zhang N; Chung DH
    PLoS One; 2022; 17(12):e0277956. PubMed ID: 36525420
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging.
    Liu S; Zhang Y; Kong Z; Jiang C; Wang Y; Zhao D; You H; Ma W; Feng F
    BMC Neurosci; 2022 Dec; 23(1):72. PubMed ID: 36471242
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Better Prognosis of Gastric Neuroendocrine Carcinoma Than Gastric Adenocarcinoma among Whites in the United States: A Propensity Score Matching Analysis Based on SEER.
    Li Z; Ren H; Zhao L; Zhang X; Wang T; Sun C; Niu P; Wang W; Fei H; Guo C; Chen Y; Zhao D
    Curr Oncol; 2022 Jul; 29(7):4879-4892. PubMed ID: 35877247
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clinicopathological, Oncogenic, and
    Chen Y; Dong Y; Shi J; Zhao L
    Contrast Media Mol Imaging; 2022; 2022():1926797. PubMed ID: 35821888
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Real-world clinicopathological features and outcome of thymic neuroendocrine tumors: a retrospective single-institution analysis.
    Chen Y; Zhang J; Zhou M; Guo C; Li S
    Orphanet J Rare Dis; 2022 Jun; 17(1):215. PubMed ID: 35668481
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Long-Term Outcomes in Head and Neck Paragangliomas Managed with Intensity-Modulated Radiotherapy.
    Rougier G; Rochand A; Bourdais R; Meillan N; Tankere F; Herman P; Riet F; Mazeron JJ; Burnichon N; Lussey-Lepoutre C; Jacob J; Simon JM; Maingon P; Feuvret L
    Laryngoscope; 2023 Mar; 133(3):607-614. PubMed ID: 35638238
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Telomere length and Wnt/β-catenin pathway in adamantinomatous craniopharyngiomas.
    Mota JIS; Silva-Júnior RMP; Martins CS; Bueno AC; Wildemberg LE; Antunes XLDS; Ozaki JGO; Coeli-Lacchini FB; Garcia-Peral C; Oliveira AER; Santos AC; Moreira AC; Machado HR; Dos Santos MV; Colli LM; Gadelha MR; Antonini SRR; de Castro M
    Eur J Endocrinol; 2022 Jun; 187(2):219-230. PubMed ID: 35584004
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pseudoretinoblastoma: Distribution based on gender, age, and laterality.
    Mirzayev I; Gündüz AK; Özalp Ateş FS; Tetik D
    Eur J Ophthalmol; 2023 Jan; 33(1):104-111. PubMed ID: 35570796
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Trends in Adjuvant External Beam Radiation Therapy for Nonanaplastic Thyroid Cancer in California, 2003-2017.
    Hu MY; Chin RK; Kim J; Tseng CH; Yeh MW; Livhits MJ; Leung AM; Wu JX
    Endocr Pract; 2022 Jul; 28(7):647-653. PubMed ID: 35231653
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Application of serum markers in medullary thyroid carcinoma].
    Han XD; Lu RQ; Hu HY; Guo L
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1468-1474. PubMed ID: 34963245
    [No Abstract]    [Full Text] [Related]  

  • 18. Adjuvant Therapy and Prognosticators of Survival in Head and Neck Mucosal Melanoma.
    Abiri A; Yasaka TM; Lehrich BM; Goshtasbi K; Papagiannopoulos P; Tajudeen BA; St John MA; Harris JP; Kuan EC
    Laryngoscope; 2022 Mar; 132(3):584-592. PubMed ID: 34355791
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Radiation Dose Rate, Biologically Effective Dose, and tumor Characteristics on Local Control and Toxicity After Radiosurgery for Acoustic Neuromas.
    Villafuerte CJ; Shultz DB; Laperriere N; Gentili F; Heaton R; van Prooijen M; Cusimano MD; Hodaie M; Schwartz M; Berlin A; Payne D; Kalia SK; Bernstein M; Wang J; Zadeh G; Spears J; Tsang DS
    World Neurosurg; 2021 Aug; 152():e512-e522. PubMed ID: 34098139
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Risk of Cancer-Specific Death for Patients Diagnosed With Neuroendocrine tumors: A Population-Based Analysis.
    Hallet J; Law C; Singh S; Mahar A; Myrehaug S; Zuk V; Zhao H; Chan W; Assal A; Coburn N
    J Natl Compr Canc Netw; 2021 Jun; 19(8):935-944. PubMed ID: 34087785
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.